Alivus Life Sciences Limited — Important, 12-08-2025: General Updates

Alivus Life Sciences (formerly Glenmark Life Sciences) reported FY25 turnover of ₹23,869 Cr and net worth of ₹28,174 Cr, with strong exports comprising 51.7% of sales to over 75 countries. The company is actively pursuing sustainability, significantly reducing its carbon footprint and improving water efficiency. Key operational improvements include adopting Nano-filtration for solvent recovery. A ₹15 Lakh fine for a past environmental violation was promptly resolved with no ongoing impact. Alivus is boosting employee well-being and community development, recognized with an award for its social impact efforts.